Vaxcyte Earnings
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 8, 10:45 AM ET
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$2.00
Vaxcyte earnings summary
Vaxcyte is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $2.00. In its most recent report on Aug 5, 2026 (Q2 2026), PCVX posted EPS of $-1.97. Across the last 16 reports, PCVX shares moved an average of 6.2% (in either direction) in the first trading session after results, rising 8 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
PCVX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-1.97 | — | 0.0% |
| May 6, 2026 | — | $-2.30 | — | -1.2% |
| Feb 24, 2026 | — | $-1.81 | — | -4.0% |
| Nov 4, 2025 | — | $-1.56 | — | +16.9% |
| Aug 6, 2025 | — | $-1.22 | — | +9.4% |
| May 7, 2025 | — | $-1.04 | — | +2.2% |
| Feb 25, 2025 | — | $-1.02 | — | -2.5% |
| Nov 5, 2024 | — | $-0.83 | — | -18.6% |
| Aug 6, 2024 | — | $-1.10 | — | +1.3% |
| May 8, 2024 | — | $-0.85 | — | +14.4% |
| Feb 27, 2024 | — | $-1.83 | — | +1.4% |
| Nov 6, 2023 | — | $-0.91 | — | +6.9% |
| Aug 8, 2023 | — | $-0.70 | — | +5.5% |
| May 8, 2023 | — | $-0.70 | — | -2.5% |
| Feb 27, 2023 | — | $-1.03 | — | -11.1% |
| Nov 7, 2022 | — | $-0.93 | — | -0.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.